Adiponectin could repress the proliferation of breast cancer cells in vitro, and decreased the expression level of ACADS meanwhile, which indicated that ACADS could be a promising biomarker in breast cancer 31. This evidence concerns the gene ADIPOQ and breast carcinoma.